AI assistant
Cryoport, Inc. — Director's Dealing 2023
Sep 5, 2023
32876_dirs_2023-09-05_f77f2efd-ad87-4d8e-88ba-40d8af0a9bba.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cryoport, Inc. (CYRX)
CIK: 0001124524
Period of Report: 2023-09-01
Reporting Person: SHELTON JERRELL (Director, See Remarks)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-09-01 | Common Stock | M | 54000 | $1.87 | Acquired | 659299 | Direct |
| 2023-09-01 | Common Stock | S | 26875 | $14.2663 | Disposed | 632424 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-09-01 | Option to purchase common stock | $1.87 | M | 54000 | Disposed | 2026-05-06 | Common Stock (54000) | Direct |
Footnotes
F1: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.09 to $14.36, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2: 1/48 of the options vested on the 6th of each month for forty-eight months beginning on May 6, 2016.